Published January 17, 2024 | Version v1
Journal article Open

The endogenous cannabinoid and the adrenergic systems in modulation of stress-response

Description

In our modern, fast-paced society, excessive stress (or distress) is a major risk factor for developing a plethora of diseases. There are several neuromediatory systems in the brain that regulate the response to stress, including the adrenergic and endocannabinoid systems. In our experiments, we study the effects of the endocannabinoid system on the restrain stress-induced analgesia (r-SIA). The experiments were done on male Wistar rats. The animals were confined in special restrainers for a period of one hour. The animals were treated with Clonidine (at 4 mg/kg) – a prototypical α2-agonist; Yohimbine – an α2-adrenergic receptor antagonist; Desipramine – a NE reuptake blocker; CB1r agonist anandamide (AEA); CB1r antagonist АМ251 in different combinations. r-SIA was investigated by means of the paw pressure test in order to get a better understanding of the role that the neurotransmitter anandamide plays in the process. The degree to which the levels of r-SIA fluctuated served as an indicator of the degree to which the cannabinoid system and the adrenergic system interacted with one another. Cannabinoids that are administered exogenously were found to reduce levels of r-SIA and modulate the effects of the adrenergic system. These conclusions were reached based on the findings of our research.

Files

PHAR_article_115659.pdf

Files (1.6 MB)

Name Size Download all
md5:12055d52f1bb064cf677be43e22ddb5e
1.5 MB Preview Download
md5:02c392b9dc6333aef1f1d36febe77fd2
105.1 kB Preview Download

Additional details

References

  • Akil H (1976) Stress-Induced Increase in Endogenous Opiate Peptides: Concurrent Analgesia and its Reversal by Naloxone. Opiates and Endogenous Opioid Peptides. North-Holland Publishing Company, 63–70.
  • Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker JM (1984) Endogenous opioids: biology and function. Annual Review of Neuroscience 7: 223–255. https://doi.org/10.1146/annurev.ne.07.030184.001255
  • Blankman JL, Simon GM, Cravatt BF (2007) A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chemistry & Biology 14: 1347–1356. https://doi.org/10.1016/j.chembiol.2007.11.006
  • Bodnar RJ, Merrigan KP, Sperber E (1983) Potentiation of cold-water swim analgesia and hypothermia by clonidine. Pharmacology Biochemistry and Behavior 19: 447–451. https://doi.org/10.1016/0091-3057(83)90118-1
  • Butler RK, Finn DP (2009) Stress-induced analgesia. Progress in Neurobiology 88: 184–202. https://doi.org/10.1016/j.pneurobio.2009.04.003
  • Cabral GA, Griffin-Thomas L (2009) Emerging role of the cannabinoid receptor CB2in immune regulation: therapeutic prospects for neuroinflammation. Expert Reviews in Molecular Medicine 11: e3. https://doi.org/10.1017/s1462399409000957
  • Carvalho AF, Mackie K, Van Bockstaele EJ (2010) Cannabinoid modulation of limbic forebrain noradrenergic circuitry. European Journal of Neuroscience 31: 286–301. https://doi.org/10.1111/j.1460-9568.2009.07054.x
  • Carvalho AF, Van Bockstaele EJ (2012) Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 38: 59–67. https://doi.org/10.1016/j.pnpbp.2012.01.008
  • Cassens G, Kuruc A, Roffman M, Orsulak PJ, Schildkraut JJ (1981) Alterations in brain norepinephrine metabolism and behavior induced by environmental stimuli previously paired with inescapable shock. Behavioural Brain Research 2: 387–407. https://doi.org/10.1016/0166-4328(81)90020-6
  • Chang M-S, Sved AF, Zigmond MJ, Austin MC (2000) Increased transcription of the tyrosine hydroxylase gene in individual locus coeruleus neurons following footshock stress. Neuroscience 101: 131–139. https://doi.org/10.1016/s0306-4522(00)00352-3
  • Crowe MS, Nass SR, Gabella KM, Kinsey SG (2014) The endocannabinoid system modulates stress, emotionality, and inflammation. Brain, Behavior, and Immunity 42: 1–5. https://doi.org/10.1016/j.bbi.2014.06.007
  • Curtis AL, Bello NT, Valentino RJ (2001) Evidence for functional release of endogenous opioids in the locus ceruleus during stress termination. The Journal of Neuroscience 21: RC152–RC152. https://doi.org/10.1523/jneurosci.21-13-j0001.2001
  • Curtis AL, Leiser SC, Snyder K, Valentino RJ (2012) Predator stress engages corticotropin-releasing factor and opioid systems to alter the operating mode of locus coeruleus norepinephrine neurons. Neuropharmacology 62: 1737–1745. https://doi.org/10.1016/j.neuropharm.2011.11.020
  • Dlugos A, Childs E, Stuhr KL, Hillard CJ, de Wit H (2012) Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology 37: 2416–2427. https://doi.org/10.1038/npp.2012.100
  • Drolet G, Gauthier P (1985) Peripheral and central mechanisms of the pressor response elicited by stimulation of the locus coeruleus in the rat. Canadian Journal of Physiology and Pharmacology 63: 599–605. https://doi.org/10.1139/y85-100
  • Finn DP (2010) Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance. Immunobiology 215: 629–646. https://doi.org/10.1016/j.imbio.2009.05.011
  • Fišar Z (2010) Inhibition of monoamine oxidase activity by cannabinoids. Naunyn-Schmiedeberg's Archives of Pharmacology 381: 563–572. https://doi.org/10.1007/s00210-010-0517-6
  • Foote SL, Bloom FE, Aston-Jones G (1983) Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiological Reviews 63: 844–914. https://doi.org/10.1152/physrev.1983.63.3.844
  • Gassen NC, Chrousos GP, Binder EB, Zannas AS (2017) Life stress, glucocorticoid signaling, and the aging epigenome: Implications for aging-related diseases. Neuroscience & Biobehavioral Reviews 74: 356–365. https://doi.org/10.1016/j.neubiorev.2016.06.003
  • Giovannitti JA, Thoms SM, Crawford JJ (2015) Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesthesia Progress 62: 31–38. https://doi.org/10.2344/0003-3006-62.1.31
  • Grzanna R, Molliver ME (1980) The locus coeruleus in the rat: An immunohistochemical delineation. Neuroscience 5: 21–40. https://doi.org/10.1016/0306-4522(80)90068-8
  • Gurtu S, Kamlesh Kumar Pant, Jagdish Narain Sinha, Krishna Prasad Bhargava (1984) An investigation into the mechanism of cardiovascular responses elicited by electrical stimulation of locus coeruleus and subcoeruleus in the cat. Brain Research 301: 59–64. https://doi.org/10.1016/0006-8993(84)90402-5
  • Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences 87: 1932–1936. https://doi.org/10.1073/pnas.87.5.1932
  • Hill MN, McLaughlin RJ, Bingham B, Shrestha L, Lee TTY, Gray JM, Hillard CJ, Gorzalka BB, Viau V (2010a) Endogenous cannabinoid signaling is essential for stress adaptation. Proceedings of the National Academy of Sciences 107: 9406–9411. https://doi.org/10.1073/pnas.0914661107
  • Hill MN, McLaughlin RJ, Pan B, Fitzgerald ML, Roberts CJ, Lee TT-Y, Karatsoreos IN, Mackie K, Viau V, Pickel VM, McEwen BS, Liu Q-s, Gorzalka BB, Hillard CJ (2011) Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. Journal of Neuroscience 31: 10506–10515. https://doi.org/10.1523/jneurosci.0496-11.2011
  • Hill MN, Patel S, Campolongo P, Tasker JG, Wotjak CT, Bains JS (2010b) Functional interactions between stress and the endocannabinoid system: From synaptic signaling to behavioral output. The Journal of Neuroscience 30: 14980–14986. https://doi.org/10.1523/JNEUROSCI.4283-10.2010
  • Huffman JC, Stern TA (2007) Neuropsychiatric consequences of cardiovascular medications. Dialogues in Clinical Neuroscience 9: 29–45. https://doi.org/10.31887/DCNS.2007.9.1/jchuffman
  • Itoi K, Sugimoto N (2010) The brainstem noradrenergic systems in stress, anxiety and depression. Journal of Neuroendocrinology 22: 355–361. https://doi.org/10.1111/j.1365-2826.2010.01988.x
  • Jentsch J (1997) Δ9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: Blockade of dopaminergic effects with HA966. Neuropsychopharmacology 16: 426–432. https://doi.org/10.1016/s0893-133x(97)00018-3
  • Kaplan JR, Chen H, Manuck SB (2009) The relationship between social status and atherosclerosis in male and female monkeys as revealed by meta‐analysis. American Journal of Primatology 71: 732–741. https://doi.org/10.1002/ajp.20707
  • Kaplan JR, Manuck SB (1994) Antiatherogenic effects of β-adrenergic blocking agents: Theoretical, experimental, and epidemiologic considerations. American Heart Journal 128: 1316–1328. https://doi.org/10.1016/0002-8703(94)90254-2
  • Katona I, Sperlágh B, SÍk A, Käfalvi A, Vizi ES, Mackie K, Freund TF (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. The Journal of Neuroscience 19: 4544–4558. https://doi.org/10.1523/JNEUROSCI.19-11-04544.1999
  • Kawamura H, Gunn CG, Frohlich ED (1978) Cardiovascular alteration by nucleus locus coeruleus in spontaneously hypertensive rat. Brain Research 140: 137–147. https://doi.org/10.1016/0006-8993(78)90243-3
  • Kinden R, Zhang X (2015) Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice. Behavioural Brain Research 284: 225–230. https://doi.org/10.1016/j.bbr.2015.02.025
  • Kollack-Walker S, Watson SJ, Akil H (1997) Social stress in hamsters: Defeat activates specific neurocircuits within the brain. The Journal of Neuroscience 17: 8842–8855. https://doi.org/10.1523/jneurosci.17-22-08842.1997
  • Koracevic G, Micic S, Stojanovic M, Radovanovic RV, Pavlovic M, Kostic T, Djordjevic D, Antonijevic N, Koracevic M, Atanaskovic V, Dakic S (2022) Beta blockers can mask not only hypoglycemia but also hypotension. Current Pharmaceutical Design 28: 1660–1668. https://doi.org/10.2174/1381612828666220421135523
  • Korf J, Aghajanian GK, Roth RH (1973) Increased turnover of norepinephrine in the rat cerebral cortex during stress: Role of the locus coeruleus. Neuropharmacology 12: 933–938. https://doi.org/10.1016/0028-3908(73)90024-5
  • Kulkarni SK (1980) Heat and other physiological stress-induced analgesia: Catecholamine mediated and naloxone reversible response. Life Sciences 27: 185–188. https://doi.org/10.1016/0024-3205(80)90136-8
  • Lacroix D, Blier P, Curet O, de Montigny C (1991) Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain. Journal of pharmacology and experimental therapeutics 257: 1081–1090. https://pubmed.ncbi.nlm.nih.gov/1646320/
  • Mackie K, Lai Y, Westenbroek R, Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. The Journal of Neuroscience 15: 6552–6561. https://doi.org/10.1523/JNEUROSCI.15-10-06552.1995
  • Makino S, Smith MA, Gold PW (2002) Regulatory role of glucocorticoids and glucocorticoid receptor mRNA levels on tyrosine hydroxylase gene expression in the locus coeruleus during repeated immobilization stress. Brain Research 943: 216–223. https://doi.org/10.1016/s0006-8993(02)02647-1
  • McEwen BS (2008) Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. European Journal of Pharmacology 583: 174–185. https://doi.org/10.1016/j.ejphar.2007.11.071
  • Mechoulam R, Parker LA (2013) The Endocannabinoid System and the Brain. Annual Review of Psychology 64: 21–47. https://doi.org/10.1146/annurev-psych-113011-143739
  • Niccoli T, Partridge L (2012) Ageing as a risk factor for disease. Current Biology 22: R741–R752. https://doi.org/10.1016/j.cub.2012.07.024
  • Nocheva H, Krastev NS, Krastev DS, Mileva M (2023) The endogenous cannabinoid and the nitricoxidergic systems in the modulation of stress responses. International Journal of Molecular Sciences 24: e2886. https://doi.org/10.3390/ijms24032886
  • Nocheva HH, Encheva-Stoykova EN, Grigorov EE (2022) Interaction between endocannabinoids and the adrenergic system before and after stress-exposure. Pharmacia 69: 249–254. https://doi.org/10.3897/pharmacia.69.e80550
  • Oropeza VC, Page ME, Van Bockstaele EJ (2005) Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex. Brain Research 1046: 45–54. https://doi.org/10.1016/j.brainres.2005.03.036
  • Page ME, Oropeza VC, Sparks SE, Qian Y, Menko AS, Van Bockstaele EJ (2007) Repeated cannabinoid administration increases indices of noradrenergic activity in rats. Pharmacology Biochemistry and Behavior 86: 162–168. https://doi.org/10.1016/j.pbb.2006.12.020
  • Patel S, Roelke CT, Rademacher DJ, Hillard CJ (2005) Inhibition of restraint stress‐induced neural and behavioural activation by endogenous cannabinoid signalling. European Journal of Neuroscience 21: 1057–1069. https://doi.org/10.1111/j.1460-9568.2005.03916.x
  • Quek CZ, Lu HT, Kam J, Leo B, Gunasekaran, Lee CY (2017) Beta-blocker use and risk of symptomatic bradyarrhythmias: A hospital-based case-control study. International Journal of Cardiology 249: S16–S17. https://doi.org/10.1016/j.ijcard.2017.09.070
  • Rademacher DJ, Meier SE, Shi L, Vanessa Ho W-S, Jarrahian A, Hillard CJ (2008) Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 54: 108–116. https://doi.org/10.1016/j.neuropharm.2007.06.012
  • Radley JJ, Kabbaj M, Jacobson L, Heydendael W, Yehuda R, Herman JP (2011) Stress risk factors and stress-related pathology: Neuroplasticity, epigenetics and endophenotypes. Stress 14: 481–497. https://doi.org/10.3109/10253890.2011.604751
  • Randall LO, Selitto JJ (1957) A method for measurement of analgesic activity on inflamed tissue. Archives Internationales de Pharmacodynamie et de Therapie 111: 409–419.
  • Reyes BAS, Szot P, Sikkema C, Cathel AM, Kirby LG, Van Bockstaele EJ (2012) Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure. Experimental Neurology 236: 327–335. https://doi.org/10.1016/j.expneurol.2012.05.016
  • Robertson SD, Plummer NW, de Marchena J, Jensen P (2013) Developmental origins of central norepinephrine neuron diversity. Nature Neuroscience 16: 1016–1023. https://doi.org/10.1038/nn.3458
  • Rozanski A, Blumenthal JA, Kaplan J (1999) Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99: 2192–2217. https://doi.org/10.1161/01.cir.99.16.2192
  • Sabban EL, Kvetňanský R (2001) Stress-triggered activation of gene expression in catecholaminergic systems: dynamics of transcriptional events. Trends in Neurosciences 24: 91–98. https://doi.org/10.1016/s0166-2236(00)01687-8
  • Scavone JL, Mackie K, Van Bockstaele EJ (2010) Characterization of cannabinoid-1 receptors in the locus coeruleus: Relationship with mu-opioid receptors. Brain Research 1312: 18–31. https://doi.org/10.1016/j.brainres.2009.11.023
  • Schwarz LA, Luo L (2015) Organization of the locus coeruleus-norepinephrine system. Current Biology 25: R1051–R1056. https://doi.org/10.1016/j.cub.2015.09.039
  • Seth B (2022) Non-opioid medication in pain medicine. Anaesthesia & Intensive Care Medicine 23: 391–394. https://doi.org/10.1016/j.mpaic.2022.03.012
  • Sgoifo A, Carnevali L, Grippo AJ (2014) The socially stressed heart. Insights from studies in rodents. Neuroscience & Biobehavioral Reviews 39: 51–60. https://doi.org/10.1016/j.neubiorev.2013.12.005
  • Sgoifo A, Koolhaas JM, Musso E, De Boer SF (1999) Different sympathovagal modulation of heart rate during social and nonsocial stress episodes in wild-type rats. Physiology & Behavior 67: 733–738. https://doi.org/10.1016/s0031-9384(99)00134-1
  • Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. The Journal of Neuroscience 16: 4322–4334. https://doi.org/10.1523/jneurosci.16-14-04322.1996
  • Skantze HB, Kaplan J, Pettersson K, Manuck S, Blomqvist N, Kyes R, Williams K, Bondjers G (1998) Psychosocial stress causes endothelial injury in cynomolgus monkeys via β1-adrenoceptor activation. Atherosclerosis 136: 153–161. https://doi.org/10.1016/s0021-9150(97)00202-5
  • Southwick SM, Bremner JD, Rasmusson A, Morgan CA, Arnsten A, Charney DS (1999) Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biological Psychiatry 46: 1192–1204. https://doi.org/10.1016/s0006-3223(99)00219-x
  • Stroth N, Holighaus Y, Ait‐Ali D, Eiden LE (2011) PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response. Annals of the New York Academy of Sciences 1220: 49–59. https://doi.org/10.1111/j.1749-6632.2011.05904.x
  • Swanson LW, Hartman BK (1975) The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine‐B‐hydroxylase as a marker. Journal of Comparative Neurology 163: 467–505. https://doi.org/10.1002/cne.901630406
  • Tam SW, Worcel M, Wyllie M (2001) Yohimbine: a clinical review. Pharmacology & Therapeutics 91: 215–243. https://doi.org/10.1016/s0163-7258(01)00156-5
  • Tzavara ET, Davis RJ, Perry KW, Li X, Salhoff C, Bymaster FP, Witkin JM, Nomikos GG (2003) The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. British Journal of Pharmacology 138: 544–553. https://doi.org/10.1038/sj.bjp.0705100
  • Tzavara ET, Perry KW, Rodriguez DE, Bymaster FP, Nomikos GG (2001) The cannabinoid CB1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus. European Journal of Pharmacology 426: R3–R4. https://doi.org/10.1016/s0014-2999(01)01228-6
  • Wang M, Hill MN, Zhang L, Gorzalka BB, Hillard CJ, Alger BE (2011) Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. Journal of Psychopharmacology 26: 56–70. https://doi.org/10.1177/0269881111409606
  • Wood GE, Young LT, Reagan LP, McEwen BS (2003) Acute and chronic restraint stress alter the incidence of social conflict in male rats. Hormones and Behavior 43: 205–213. https://doi.org/10.1016/s0018-506x(02)00026-0
  • Wood SK, Valentino RJ (2017) The brain norepinephrine system, stress and cardiovascular vulnerability. Neuroscience & Biobehavioral Reviews 74: 393–400. https://doi.org/10.1016/j.neubiorev.2016.04.018
  • Zain MA, Pandy V, Majeed ABA, Wong WF, Mohamed Z (2019) Chronic restraint stress impairs sociability but not social recognition and spatial memoryin C57BL/6J mice. Experimental Animals 68: 113–124. https://doi.org/10.1538/expanim.18-0078